XM does not provide services to residents of the United States of America.

Dow leads Wall St revival after inflation data; tech stocks recoup losses



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>US STOCKS-Dow leads Wall St revival after inflation data; tech stocks recoup losses</title></head><body>

For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.

PCE inflation rises moderately in June

Russell 2000 hits one-week high

Deckers, Baker Hughes climb after results

Dexcom slips after cutting revenue forecast

Indexes up: Dow 1.63%, S&P 1.06%, Nasdaq 0.92%

Updated at 11:46 a.m. ET/1546 GMT

By Ankika Biswas and Lisa Pauline Mattackal

July 26 (Reuters) - Wall Street bounced back on Friday with the blue-chip Dow leading the charge as some megacap tech and chip stocks recovered from the week's pummeling, while a largely in-line key inflation reading kept bets of an early rate cut alive.

Industrial conglomerate 3M MMM.N jumped19%, boosting the Dow to a one-month high after itraised the lower end of its annual adjusted profit forecast.

The Philadelphia SE Semiconductor index .SOX was on track to snap a three-day losing streak as Nvidia NVDA.O, Marvell Technology MRVL.O, Broadcom AVGO.O, Texas Instruments TXN.O and Qualcomm QCOM.O rose more than 1% each.

The Magnificent Seven stocks were mixed, with Microsoft MSFT.O and Meta Platforms META.O gaining more than 1%, while Tesla TSLA.O and Alphabet GOOGL.O shed 0.7% and 2%, respectively.

The 10-year Treasury yield US10YT=RR turned lower after the inflation data. US/

Economically sensitive small-cap stocks rose, with the Russell 2000 .RUT jumping 1%, set for its third straight weekly gain in two months and its best three-week run since August 2022.

The moderate rise in U.S. prices underlined an improving inflation environment, potentially positioning the Federal Reserve to start easing policy in September. The central bank's July monetary policy decision is due next week.

"A cut next Wednesday is unlikely, but the Fed can at least acknowledge that they're more confident in the disinflationary trends," said Brian Jacobsen, chief economist at Annex Wealth Management. "The markets should warmly greet that."

Bets of a 25-basis-point cut by the Fed's September meeting held steady at about 88% after the PCE reading, according to CME's FedWatch. Traders still largely expect two rate cuts by December, according to LSEG data.

At 11:46 a.m. ET, the Dow Jones Industrial Average .DJI was up 652.82 points, or 1.63%, at 40,587.89, the S&P 500 .SPX was up 57.19 points, or 1.06%, at 5,456.41, and the Nasdaq Composite .IXIC was up 158.56 points, or 0.92%, at 17,340.28.

However, the S&P 500 and the Nasdaq remained on track for a second straight week of losses after investors dumpedtech stocks over thepast few weeks. Disappointing earnings from Alphabet and Tesla sparked a steep sell-offin megacap and artificial-intelligence-linked shareson Wednesday.


Worries about WallStreet's growing dependence on a set of high-momentum stocks, whose valuations now appear inflated, have made underperformingsectors like mid- and small-cap stocks seem more attractive, now thatearly rate cuts seem likely.

Industrials .SPLRCI and Materials .SPLRCM led gains across the S&P 500 sector indexes. Energy .SPNY bucked the trend and fell tracking lower oil prices.

In earnings, DeckersOutdoor DECK.N jumped 8.0% after it raisedits annual profit forecast, while oilfield services firm Baker Hughes BKR.O climbed 3.3% after beating estimates for second-quarter profit.

Medical device maker Dexcom DXCM.O slumped 42.0% after cutting its annual revenue forecast.

Of the 206 companies in the S&P 500 that have reported second-quarter earnings till date, 78.6% beat analysts' expectations, according to LSEG data.

Advancing issues outnumbered decliners by a 3.46-to-1 ratio on the NYSE, andby a 2.05-to-1 ratio on the Nasdaq.

The S&P index recorded six new 52-week highs, while theNasdaq recorded 161 new highs and 39 new lows.


U.S. stocks weekly performance https://tmsnrt.rs/3yauR7f


Reporting by Ankika Biswas and Lisa Mattackal in Bengaluru; Editing by Saumyadeb Chakrabarty and Pooja Desai

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.